Glenmark Pharmaceuticals has informed that it enclosed a media release titled ‘Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial).
The above information is a part of company’s filings submitted to BSE.